Views & Analysis What doctors say about the EU referendum Daniel Ghinn tunes into the conversation around the EU referendum, which takes place on Thursday
Articles Pharma warns of European exit – but British public needs mor... If there is one thing that big pharma companies hate more than anything, it's uncertainty about the future of their markets and regulations.
News ESC26: AZ's relaxin agonist shows promise in heart failure An oral relaxin agonist developed by AstraZeneca, codenamed AZD5462, has been shown to improve cardiac function in patients with heart failure.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
